Medical Device News Magazine

New Survey: 84% of Respondents Would Participate in a Hospital-at-Home Program In Order To Get Home Sooner

Vivalink’s survey reveals strong consumer support for flexible care models, indicating a need for home based care as part of the national healthcare system

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

More than 300 Hospital at Home (HaH) programs have been approved across the country, allowing thousands of patients to be monitored in the comfort of their homes after leaving the hospital.

Vivalink, a leading provider of digital healthcare solutions, is sharing results from a new survey of more than 1,000 U.S. consumers 40 years and older about their opinions surrounding participating in a HaH program.

Key findings from the survey include:
  • An overwhelming 84% of respondents are willing to participate in HaH monitoring in order to return home sooner versus staying at the hospital to be monitored. 

  • 77% of respondents indicated that they would trust their healthcare provider’s recommendation to utilize HaH monitoring.

  • Of those who have experienced HaH, 84% reported having a positive experience with the program.

  • 49% of respondents who had participated in a HaH program found the remote patient monitoring (RPM) device easy to use. At the same time, of the 16% of respondents who were not likely to participate in HaH programs, difficulty with devices was cited as a top concern.
The survey also delved into demographic variations, uncovering insights based on age and location:
  • Older respondents (over 70) were less likely to have heard of HaH programs (42% vs. 77% of consumers in their 40s), or had participated in HaH programs (11% vs. 66%).

  • Urban participants were more likely to have participated in HaH programs (71% vs. 25% of rural respondents) but were less likely to prefer completely remote primary care compared to rural participants (19% vs. 36% of rural respondents). 

  • Respondents with three or more hospitalizations in the last 12 months demonstrated a higher willingness to participate in HaH programs (95% vs. 62% of respondents with 2 or fewer hospitalizations) and expressed greater trust in providers’ recommendations for HaH monitoring (95% vs 78%).
The survey’s findings are particularly compelling as the waivers introduced by the Centers for Medicare and Medicaid Services (CMS) in response to the COVID-19 pandemic, which allowed inpatient-level hospital services to be conducted in patients’ homes, are set to expire at the end of this year, emphasizing the need for permanent adoption of flexible care models like HaH programs.

“Consumers are increasingly driving the trend towards receiving care in the comfort of their own homes. This shift, accelerated by the COVID pandemic, underscores the importance of providing flexible and convenient healthcare solutions that meet patients’ evolving needs,” said Jiang Li, CEO of Vivalink. “At Vivalink, we are committed to the development of advanced digital healthcare solutions in order to improve access and efficiency of the healthcare system for all.”

For more details and infographics, click here.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”